This research introduces classifications of epileptic psychoses, current views on etiopathogenic mechanisms of epileptic psychoses development, different aspects and types of their course, considers modern recommendation and describes presentation of epileptic psychoses as well as major approaches to their treatment. The article presents the results of Quetiapine administration in the treatment of epileptic psychoses.
INTRODUCTION
The issue of epileptic psychoses has recently received the deepest attention due to the fact that patients who suffer from this pathology quite often get full-time treatment in psychiatric clinics as well as receiving necessary aid in out-patient psychiatric institutions. According to the WHO data epileptic psychoses vary in different countries within 2.5% to 8% and mostly depend on the prevailing type of psychotic disorder [1] . Most common are epileptic psychoses of transitory (acute) type (64%) and paroxysmal type (24-28%) with chronic epileptic psychoses being observed much more rarely (8-12%).
Developing efficient strategies for correcting and preventing epileptic psychotic disorders remains an urgent issue in clinical practice since the current level of expertise in this pathology does not provide an unanimous understanding of the pathogenesis of these disorders. The majority of epileptic patients have various psychotic disorders, and the probability of their development increases proportionally to the disease duration. Their origin is determined by a variety of factors, such as the patient's age at the beginning of the disease, the form of epilepsy, its type, the disease resistance to pharmacotherapy, the patient's compliance level, anti-epileptic drugs intake in regular and adequate dosage, additional health hazards, accompanying disorders and duration of the disorder.
Significance of epileptic psychoses is preconditioned by both difficulties of differential diagnosis (the difficulty of differential diagnosis of organic and epileptic psychoses is determined by the primary cause of epilepsy onset since epileptic psychoses may as well be regarded as organic ones once the morphological basis is proven) and the present social and economic consequences for the society and inter-ictal (emerge in the inter-seizure period and are not connected with epileptic seizures). Inter-ictal psychoses are mostly acute or chronic.
There is also a separate type of epileptic psychoses, particularly alternating psychosis being regarded to as inter-ictal psychosis also referred to as Landolt syndrome.
The development of this kind of psychosis is associated 
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According to various studies, the development of psychoses is determined by epileptic disorders in neuron activity mostly in limbic structures related to emotion and motivation regulation, complex automatic forms of behavior, which is proven by EEG examinations. Specific changes and dynamics of bioelectrical brain activity while developing psychoses are characterized by an increase and expansion of the epileptic system, low-rate low-amplitude diffusion activity in combination with hyporeactivity to external stimuli for spontaneous psychoses formation or a decrease in intensity of epilepsy mechanism of brain functioning with desynchronization phenomena while developing psychotic states with alternative formation mechanism [7] .
Epileptic process in the brain itself is the main factor for psychoses development in epilepsy, which is of fire of poly- Quetiapine and its active metabolite norquetiapine act as antagonists to dopamine D2-receptors with moderate affinity [13, 14] , norquetiapine increases the concentration of the pre-frontal dopamine and serotonin [13, 15] , blocks the presynaptic receptors 5-HT7 [14, 15] , which explains its antipsychotic effect and the influence on the wide spectrum of affective and cognitive disorders. Improvement of cognitive functions in patients treated for schizophrenia and other psychoses can be explained by its low relationship and quick dissociation with dopamine D2-receptors [13, 14, 15] , in this research patients were given a medium drug dose -600 mg a day. According to Chang et al., 2012 Dell`Osso et al., 2012, it can improve life quality in any forms of affective disorders. Quetiapine is a pleiotropic drug which can affect a few targets and can be efficient for treating various psychotic disorders [14] .
Quetiapine treatment stipulates symptomatic remission and improves the life quality [15] . In the research by Miljevk et al., 2013 quetiapine demonstrated the neuroprotective effect, within the oxidant system, the drug promoted a decrease in superoxide dismutase and prooxidant effects, antioxidant inhibition, induced hydrogen peroxide in vitro [13, 14, 15] and was capable of protecting cell cultures from oxidative stress related to cytotoxicity induced by the β-amyloid [13, 15] . These data prove the important role of the drug in reducing the level of active intracellular oxygen and calcium forms, which enhances its antioxidant properties [13, 14, 15] . It can also prevent overproduction of intracellular enzymes of superoxide dismutase, catalase, glutathione peroxidase [14, 15] . Other neuroprotective effects of quetiapine include its capability of removing neurogenesis oppression in hippocampus caused by chronic stress [13, 14, 15] .
PURPOSES, SUBJECTS and METHODS:

Purpose
The aim of the study was to study the quetiapine clinical effectiveness for treating patients with epileptic psychoses.
Subjects & Methods
The 
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RESULTS AND DISCUSSION
In the process of research, the initial therapeutic effect for most of the patients was observed during the first week of drug titration (52.6% of patients) and was manifested by sleep improvement, reducing the intensity and duration of psychotic affect; the patients had more gentle and moderate attacks and were more responsive to the surroundings. 
